Features of intestinal T-cell lymphomas in Chinese population without evidence of celiac disease and their close association with Epstein-Barr virus infection

Chinese Medical Journal

Volumn 118, Issue 18, 2005, Pages 1542-1548

  Zhang, Wen Yan ^a   Li, Gan Di ^a   Liu, Wei Ping ^a   Ouyang, Qin ^a   Ren, Xing Chang ^a   Li, Feng Yuan ^a   Xu, Huan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Epstein Barr virus; Gamma chain T cell antigen receptor; Gene rearrangement; Immunophenotype; Intestinal T cell lymphoma; Pathology

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RO ANTIGEN; CD56 ANTIGEN; CD68 ANTIGEN; CD8 ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; LATENT MEMBRANE PROTEIN 1; PREDNISOLONE; PREDNISONE; T LYMPHOCYTE RECEPTOR GAMMA CHAIN; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CECUM; CELIAC DISEASE; CHINESE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; FEVER; FOLLOW UP; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE REARRANGEMENT; HEMATOCHEZIA; HISTOPATHOLOGY; HUMAN; ILEUM; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INCIDENCE; INTESTINE LYMPHOMA; INTESTINE RESECTION; LYMPHOID TISSUE; MALE; NATURAL KILLER CELL; POLYMERASE CHAIN REACTION; PROGNOSIS; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; T CELL LYMPHOMA; TISSUE DISTRIBUTION; VIRUS INFECTION;

ADOLESCENT; ADULT; CELIAC DISEASE; CHILD; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENE REARRANGEMENT, GAMMA-CHAIN T-CELL ANTIGEN RECEPTOR; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; INTESTINAL NEOPLASMS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; RNA, VIRAL; VIRAL MATRIX PROTEINS;

EID: 26044453579     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Greiner TC, Medeiros U, Jaffe ES. Non-Hodgkin's lymphoma. Cancer 1995;75(suppl):370-380.
2. Crump M, Gospodarowicz M, Shepherd FA, et al. Lymphoma of the gastrointestinal tract. Semin Oncol 1999;26:324-337.
3. Franssila KO, Jaser N, Sivula A. Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adult cases with a follow-up of 10-15 years. APMIS 1993;101:631-641.
4. Isaacson PG, Spencer J, Connolly CE, et al. Malignant histiocytosis of the intestine: a T-cell lymphoma. Lancet 1985;11:688-691.
5. Domizio P, Owen RA, Sheperd NA, et al. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol 1993;17:429-442.
6. Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumor. Pathology and genetics of tumors of haematopoietic and lymphoid tissues. International agency for research on cancer (IARC) Press, Lyon 2001;274-279.
7. Li G, Ouyang Q, Liu K, et al. Primary non-Hodgkin's lymphoma of the intestine: a morphological, immunohistochemical and clinical study of 31 Chinese cases. Histopathology 1994;25:113-121.
8. Ren X, Liu W, Li G, et al. Epstein-Barr virus infection and expression of T-cell intracellular antigen-1 (TIA-1) in intestinal T-cell lymphoma. Chin J Pathol (Chin) 1999;28:348-351.
9. Chan AC, Ho JW, Chiang AK, et al. Phenotypic and cytotoxic characteristics of peripheral T-cell and NK-cell lymphomas in relation to Epstein-Barr virus association. Histopathology 1999;34:16-24.
10. + intestinal lymphomas are CD8 + CD5- T-cell lymphomas of monomorphic small to medium size histology. Am J Pathol 1998;153:1483-1490.
11. Hsiao CH, Lee WI, Chang SL, et al. Angiocentric T-cell lymphoma of the intestine: a distinct etiology of ischemic bowel disease. Gastroenterology 1996;110: 985-990.
12. Lee SS, Jang JJ, Cho KJ, et al. Epstein-Barr virus-associated primary gastrointestinal lymphoma in non-immunocompromised patients in Korea. Histopathology 1997;30:234-242.
13. Kim YS, Paik SR, Kim HK, et al. Epstein-Barr virus and CD21 expression in gastrointestinal tumors. Pathol Res Pract 1998;194:705-711.
14. Yang WI, Cho MS, Tomita Y, et al. Epstein-Barr virus and gastrointestinal lymphomas in Korea. Yonsei Med J 1998;39:268-276.
15. Lee YS, Kang CS, Kim BK, et al. Extranasal T/NK-cell lymphoma presenting as intestinal diverticulum. J Korean Med Sci 2000;15:229-232.
16. Huh J, Cho K, Heo DS, et al. Detection of Epstein-Barr virus in Korean peripheral T-cell lymphoma. Am J Hematol 1999;60:205-214.
17. Katoh A, Ohshima K, Kanda M, et al. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delda T cell and natural killer cells. Leuk Lymphoma 2000;39:97-111.
18. de Bruin PC, Jiwa NM, Oudejans JJ, et al. Epstein-barr virus in primary gastrointestinal T cell lymphomas: association with gluten-sensitive enteropathy, pathological features, and immunophenotype. Am J Pathol 1995;146-861-867.
19. Quintanilla-Martinez L, Lome-Maldonado C, Off G, et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997;89:644-651.
20. Chott A, Vesely M, Simonitsch I, et al. Classification of intestinal T-cell neoplasms and their differential diagnosis. Am J Clin Pathol 1999; 111 (1 Suppl 1): S68-S74.
21. Benhattar J, Delacretaz F, Martin P, et al. Improved polymerase chain reaction detection of clonal T-cell lymphoid neoplasms. Diagn Mol Pathol 1995;4:108-112.
22. McCarthy KP, Sloane JP, Kabarowski JH, et al. A simplified method of detection of clonal rearrangement of the T-cell receptor-γchain gene. Diagn Mol Pathol 1992;1:173-179.
23. Weiss LM, Jaffe ES, Liu XF, et al. Detection and localization of Epstein-Barr viral genomees in angio-immunoblastic lymphadenopathy and angio-immunoblastic lymphadenopathy-like lymphoma. Blood 1992;79:1789-1795.
24. Gale J, Simmonds PD, Mead GM, et al. Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol 2000;18:795-803.
25. Widjaja A, Wagner S, Mix H, et al. Malabsorption with progressive weight loss and multiple intestinal ulcers in a patient with T-cell lymphoma. Z Gastroenterol 1999; 37:611-614.
26. Kanavaros P, Briere J, Emile J-F, et al. Epstein-Barr virus in T and natural killer( NK) cell non-Hodgkin's lymphomas. Leukemia 1996;10 Suppl 2:S84-S87.
27. Gregory CD, Dive C, Henderson S, et al. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 1991;349:612-614.
28. Pan L, Diss TC, Peng H, et al. Epstein-Barr virus in enteropathy-associated T-cell lymphoma (ETCL). J Pathol 1993;170:137-143.
29. Lorenzen J, Liu WP, Li GD, et al. Nasal T/NK cell lymphoma: a clicicopathologic study of 30 west Chinese patients with special reference to proliferation and apoptosis. Leuk Lymphoma 1996;23:593-602.
30. Harabuchi Y, Imai S, Wakashima J, et al. Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studies. Cancer 1996;77:2137-2149.
31. Liu W, van Gorp J, Li G. Epstein-Barr virus infection in midline malignant reticulosis. Chin J Oncol (Chin) 1997;19:49-52.
32. Peh SC, Quen QW. Nasal and nasal-type natural killer ( NK )/T-cell lymphoma: immunophenotype and Epstein-Barr virus (EBV) association. Med J Malaysia 2003;58:196-204.
33. Liu W, Chan AC, Ho FC. Expression of cytotoxic-granule-associated protein TIA-1 in nasal NK/T cell lymphomas and lymphoid hyperplasia. Chin J Pathol (Chin) 1998;27:247-250.